Hypothermic effect of 5-HT1A receptor agonist: Comparison of intranasal, intraperitoneal, and subcutaneous routes of administration

Bulletin of Experimental Biology and Medicine

Volumn 146, Issue 4, 2008, Pages 433-435

  Popova, N K ^a   Tibeikina, M A ^a   Amstislavskaya, T G ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

5 HT1A receptors; 8 OH DPAT; Intranasal, subcutaneous, intraperitoneal administration

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; BODY TEMPERATURE MONITORING; CONTROLLED STUDY; DRUG EFFECT; GENOTYPE; HYPOTHERMIA; INBRED STRAIN; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; STRAIN DIFFERENCE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADMINISTRATION, INTRANASAL; ANIMALS; BODY TEMPERATURE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED DBA; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 64749090824     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-009-0304-x     Document Type: Article

References (5)

1. T. Furubayashi, A. Kamaguchi, K. Kawaharada, et al., Biol. Pharm. Bull, 30, No. 3, 608-611 (2007).
2. E. M. Kondaurova, D. V. Bazovkina, A. V. Kulikov, and N. K. Popova, Genes Brain Behav., 5, No. 8, 596-601 (2006).
3. X. Liu, D. Peprah, and H. K. Gershenfeld, J. Psychiatr. Res., 37, No. 3, 249-259 (2003).
4. N. K. Popova, V. S. Naumenko, I. Z. Plysnina, and A. V. Kulikov, J. Neurosci. Res., 80, No. 2, 286-292 (2005).
5. Q. Z. Zhang, X. G. Jiang, and C. H. Wu, Acta Pharmacol. Sin., 25, No. 4, 522-527 (2004).